Cromos Pharma’s Türkiye Country Head Speaks at Biruni University Event in Istanbul

We are pleased to announce that Seniz Sagol, Cromos Pharma’s Country Head for Türkiye, was among the speakers at a significant industry event organized by Biruni University Medical Faculty in Istanbul this week. The GCP Training, endorsed by the Ministry of Health, aimed to elevate industry standards and practices.

Seniz contributed with two sessions titled “Clinical Trial Protocol” and “Terminology in Clinical Research,” providing valuable insights into critical aspects of clinical research. The event also featured sessions led by members of the university’s Rectorship, Hospital Directors, and Professors, each bringing their expertise to the table. 

These initiatives reflect Türkiye’s active engagement in the development of clinical research, contributing significantly to its growth in the region. 

Cromos Pharma proudly supports the Right2hope initiative, empowering patients to explore treatment options beyond traditional clinical trials. Through an intuitive, AI-supported matching algorithm, Right2hope connects patients with the most relevant expanded access, compassionate use, and right-to-try programs.